DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)
RLAY
RELAY THERAPEUTICS INC
258 institutions still hold RELAY THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 75943R102·Biological Products, (No Diagnostic Substances)·258 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
258 institutions reported RLAY in Q1 2026. SB INVESTMENT ADVISERS (UK) LTD leads at 19.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 13
238 more holders available. Log in →